Bone Density Conservation Agents

All categories
DBCAT000089Therapeutic category

Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. A DrugBank category of 34 drugs. 27 of them are approved.

Also known as
Antiresorptive Agents · Antiresorptive Drugs · Bone Resorption Inhibitors · Bone Resorption Inhibitory Agents · Inhibitors, Bone Resorption
Drugs

and 9 more with a free account

What you can answer from here — as of August 24, 2016

34DrugsEach linked to its full drug card
Sign in
43Drug targetsEvery drug–target pair in the class, with bond type
Sign in
6,575Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
13Routes of administrationHow the drugs in this class are given
Sign in
2SubcategoriesNarrower classes within this one
Sign in

Which targets do Bone Density Conservation Agents share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In